Enabling Clinical Uptake of Higher-Plex Technologies in IHC/ISH
Time: 3:00 pm
day: Day 2 Track A PM
Details:
• Multiplex immunohistochemistry and in situ hybridization assays are used in early therapeutic development and are becoming increasingly pervasive within the diagnostic workflow
• More complicated clinical questions are arising that may require multi-omics-based clinical diagnostic assays
• Issues in translating diagnostic data from preclinical to translational to clinical use
• Transition points of the diagnostic strategy from translational and clinical therapeutic development stages to include system considerations, clinical trials, and regulatory considerations
• Future challenges & opportunities in Spatial biology to support a goal of a better precision medicine approach
More Speakers to be Confirmed, Leica
